IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

FLORHAM PARK, N.J., September 07, 2023--Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro

Related Keywords

Japan ,Osaka ,United States ,Japanese ,David Nicolau ,Isao Teshirogi ,Olga Lomovskaya ,Shionogi Co Ltd ,Head Office ,Antimicrobial Surveillance Program ,Qpex Biopharma Inc ,Global Antibiotic Research ,Surveillance Program ,Clinton Health Access Initiative ,Development Partnership ,Shionogi Inc ,Chief Executive Officer ,Qpex Biopharma ,Senior Vice President ,Clinical Microbiology ,Pipeline Part ,Japanese Clinical Practice ,Post Marketing Surveillance ,Interim Analysis ,Taste Disorder ,Smell Disorder ,Combined Results ,Controlled Trials ,Population Pharmacokinetic Analysis ,Severe Acute Respiratory Syndrome Coronavirus ,Infections Treated ,Retrospective Cefiderocol Chart Review ,First Dose ,Cefiderocol Use ,Treating Patients ,Confirmed Stenotrophomonas ,During January ,Real World Use ,Cefiderocol Treating ,Confirmed Gram Negative Infections ,United States Hospitals ,Cefiderocol Activity Against Multidrug Resistant ,Molecularly Characterized Pseudomonas ,Clinical Isolates Causing Infection ,Comparator Agents Against Difficult ,Treat Resistance ,Gram Negative Isolates ,Collected During ,Comparator Agents Against Achromobacter ,Burkholderia Isolates ,Comparator Agents Against Pediatric Isolates ,Infection Type ,Antimicrobial Activity ,Comparator Agents Against Isolates ,Determining Effect ,Disk Source ,Broth Microdilution ,Disk Diffusion Testing ,Learning Lounge ,Clinical Data ,Industry Education Evening ,Medicines Patent Pool ,Full Prescribing Information ,Important Safety Information ,Shionogi ,Stenotrophomonas Maltophilia ,Poster ,Pseudomonas Aeruginosa ,